1:2:1 Podcast

Christopher Scott on human embryonic stem cell lines

For the past eight years, scientists who wanted to use federal funds for research on human embryonic stem cells had to restrict their studies to 21 cell lines approved by the National Institutes of Health. But an analysis by Christopher Scott, director of Stanford’s Program on Stem Cells in Society, suggests that only two of those lines have been used routinely. Scott discusses his findings in this podcast.

Length: 19 mins. 29 sec.

Leading in Precision Health

Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise. 

A Legacy of Innovation

Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.